No argument B on HCQ witin the prescriptive boundaries already set for autoimmune disorders and the like....
https://www.nature.com/articles/s41421-020-0156-0
progressing to the next set of trials is key....potential govt fast track to undertake same with funding round...again key
Contentious sure......potential progression on the back of more clinical trials .....potential winner.
